Taiwan FDA registration f185405072b8574772c27aefe7988442
"Siemens" lipoprotein A-1 & B corrector
TW: “西門子”脂蛋白元 A-1 & B 校正品
Taiwan·Risk Class 2·SIEMENS HEALTHCARE DIAGNOSTICS INC.;; RANDOX LABORATORIES LTD.·Registered Jul 01, 2008 – Jul 01, 2028ActiveRegistration details
- Analysis ID
- f185405072b8574772c27aefe7988442
- Customs Code
- DHA00601940001
Company information
- Manufacturer Country
- United Kingdom;;United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
Product details
- Intended Use
- In vitro diagnostic tests for the detection of lipoprotein A-1 (APO A-1) and lipoprotein B (APO B) by the ADVIA biochemical analysis system.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 Calibrated Products
- Import Information
- import
Dates and status
- Registration Date
- Jul 01, 2008
- Expiry Date
- Jul 01, 2028
About this record
Access comprehensive regulatory information for "Siemens" lipoprotein A-1 & B corrector in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f185405072b8574772c27aefe7988442 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.;; RANDOX LABORATORIES LTD.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices